BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 35477497)

  • 1. Engineered probiotics.
    Ma J; Lyu Y; Liu X; Jia X; Cui F; Wu X; Deng S; Yue C
    Microb Cell Fact; 2022 Apr; 21(1):72. PubMed ID: 35477497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced probiotics: bioengineering and their therapeutic application.
    Parvin T; Sadras SR
    Mol Biol Rep; 2024 Feb; 51(1):361. PubMed ID: 38403783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering probiotics as living diagnostics and therapeutics for improving human health.
    Zhou Z; Chen X; Sheng H; Shen X; Sun X; Yan Y; Wang J; Yuan Q
    Microb Cell Fact; 2020 Mar; 19(1):56. PubMed ID: 32131831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment.
    Huang Y; Lin X; Yu S; Chen R; Chen W
    ACS Synth Biol; 2022 Oct; 11(10):3134-3153. PubMed ID: 36094344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering probiotics for therapeutic applications: recent examples and translational outlook.
    Aggarwal N; Breedon AME; Davis CM; Hwang IY; Chang MW
    Curr Opin Biotechnol; 2020 Oct; 65():171-179. PubMed ID: 32304955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice.
    Zou ZP; Du Y; Fang TT; Zhou Y; Ye BC
    Cell Host Microbe; 2023 Feb; 31(2):199-212.e5. PubMed ID: 36758520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Probiotics for Inflammatory Bowel Disease.
    Pesce M; Seguella L; Del Re A; Lu J; Palenca I; Corpetti C; Rurgo S; Sanseverino W; Sarnelli G; Esposito G
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered probiotics.
    Steidler L
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):861-76. PubMed ID: 14507594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient engineered probiotics using synthetic biology approaches: A review.
    Yadav M; Shukla P
    Biotechnol Appl Biochem; 2020 Jan; 67(1):22-29. PubMed ID: 31538358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
    Vanderpool C; Yan F; Polk DB
    Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics in infective diarrhoea and inflammatory bowel diseases.
    Gionchetti P; Rizzello F; Venturi A; Campieri M
    J Gastroenterol Hepatol; 2000 May; 15(5):489-93. PubMed ID: 10847433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases.
    Debnath N; Yadav P; Mehta PK; Gupta P; Kumar D; Kumar A; Gautam V; Yadav AK
    Biotechnol Bioeng; 2024 Jan; 121(1):100-117. PubMed ID: 37881101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut flora in health and disease: potential role of probiotics.
    Heselmans M; Reid G; Akkermans LM; Savelkoul H; Timmerman H; Rombouts FM
    Curr Issues Intest Microbiol; 2005 Mar; 6(1):1-7. PubMed ID: 15751747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.
    Shen H; Zhao Z; Zhao Z; Chen Y; Zhang L
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases.
    Meng J; Liu S; Wu X
    Crit Rev Microbiol; 2024 May; 50(3):300-314. PubMed ID: 36946080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
    Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
    World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering Diagnostic and Therapeutic Gut Bacteria.
    Landry BP; Tabor JJ
    Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered Bacteria-Based Living Materials for Biotherapeutic Applications.
    Omer R; Mohsin MZ; Mohsin A; Mushtaq BS; Huang X; Guo M; Zhuang Y; Huang J
    Front Bioeng Biotechnol; 2022; 10():870675. PubMed ID: 35573236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene editing and genetic engineering approaches for advanced probiotics: A review.
    Yadav R; Kumar V; Baweja M; Shukla P
    Crit Rev Food Sci Nutr; 2018 Jul; 58(10):1735-1746. PubMed ID: 28071925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
    Celiberto LS; Bedani R; Rossi EA; Cavallini DC
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.